However, preliminary results from a phase II study applying PD-1 blockade in relapsed/refractory CLL, including patients with Richter’s transformation, showed promising clinical activity on the transformed cells, but not against the untransformed CLL clone [47], which might support the absence of PD-L1 on the CLL clone. Here, CD274 is linked to B-cell chronic lymphocytic leukemia.